Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arts, Society & Me.
Press releases published on April 30, 2025
Actuate Therapeutics to Participate in Citizens Life Sciences Conference 2025
GlobeNewswire
·
April 30, 2025
CHICAGO and FORT WORTH, Texas, April 30, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult …
trivago Delivers 22% Revenue Growth and Raises Full-Year Guidance
GlobeNewswire
·
April 30, 2025
Exhibit 99.1 Operating and Financial Review DÜSSELDORF, GERMANY - April 30, 2025 – trivago N.V. (NASDAQ: TRVG) (the “Company”, “we,” “us,” “our,” or “trivago,”) announced financial results for the first quarter ended March 31, 2025. Highlights: Total …
Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
GlobeNewswire
·
April 30, 2025
BETHESDA, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …
Jeffs’ Brands Enters Into a Definitive Agreement to Sell Key U.S. Assets to a Canadian Public Company for an Approximate Valuation of $11.8 Million
GlobeNewswire
·
April 30, 2025
The transaction includes the acquisition of Jeffs’ Brands’ wholly-owned subsidiary, Smart Repair Pro, and its approximately 49.1% ownership interest in SciSparc Nutraceutical Inc. by a Canadian public company in exchange for an up to 90% equity interest ( …
Context Therapeutics Presents Preclinical and Translational Data for CT-95, a Mesothelin Targeting T Cell Engager, at 2025 AACR Annual Meeting
GlobeNewswire
·
April 30, 2025
Preclinical data demonstrates unique binding location of CT-95 on mesothelin and avoidance of binding to shed mesothelin Data supports ongoing Phase 1 clinical trial for CT-95 PHILADELPHIA, April 30, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“ …
Nexxen to Announce First Quarter 2025 Financial Results on May 14, 2025
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, will release its financial results for the …
NanoXplore to Host a Webcast to Discuss Third Quarter Results on May 14th, 2025
GlobeNewswire
·
April 30, 2025
MONTREAL, April 30, 2025 (GLOBE NEWSWIRE) -- NanoXplore Inc. (“NanoXplore”) (TSX: GRA and OTCQX: NNXPF) is pleased to hold a webcast to discuss the results of its third quarter ended March 31st, 2025, on Wednesday, May 14, 2025, at 10:00 a.m. Eastern Time. …
NanoXplore organise une webdiffusion pour discuter des résultats du troisième trimestre le 14 mai 2025
GlobeNewswire
·
April 30, 2025
MONTRÉAL, 30 avr. 2025 (GLOBE NEWSWIRE) -- NanoXplore Inc. (" NanoXplore " ou la " Société ") (TSX : GRA et OTCQX : NNXPF) a le plaisir d'organiser une webdiffusion pour discuter des résultats de son troisième trimestre clos le 31 mars 2025, le mercredi 14 …
Age, previous sports experience, stronger predictors of performance in children than previous concussions, York University study finds
GlobeNewswire
·
April 30, 2025
Toronto, April 30, 2025 (GLOBE NEWSWIRE) -- A new study from York University’s Faculty of Health may offer reassuring news for parents whose children have a history of concussion, but want to get back to playing sports. Researchers from York University’s …
Anavex Life Sciences to Participate in The Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, …
TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update
GlobeNewswire
·
April 30, 2025
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday, May 5, 2025, at 8:30 AM ET to discuss results for the first quarter of 2025 and provide a business outlook for …
Altimmune to Participate in the Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
GAITHERSBURG, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate in a fireside chat at the Citizens Life …
Cielo Announces Settlement Agreement and Shareholder Meeting
GlobeNewswire
·
April 30, 2025
CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- Cielo Waste Solutions Corp. (TSXV: CMC; OTC PINK: CWSFF) (“Cielo” or the “Company”) is pleased to announce that it has reached an agreement (the “Settlement Agreement”) with Expander Energy Inc. (“ …
InflaRx to Report First Quarter 2025 Results on May 7, 2025
GlobeNewswire
·
April 30, 2025
JENA, Germany, April 30, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that it will report its first quarter 2025 financial …
Hepsiburada Announces Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
April 30, 2025
ISTANBUL, April 30, 2025 (GLOBE NEWSWIRE) -- D-MARKET Electronic Services …
Brookfield Infrastructure Reports Solid First Quarter 2025 Results
GlobeNewswire
·
April 30, 2025
BROOKFIELD, News, April 30, 2025 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners L.P. (Brookfield Infrastructure, BIP, or the Partnership) (NYSE: BIP; TSX: BIP.UN) today announced its results for the first quarter ended March 31, 2025. “We delivered …
BioCryst to Present at Upcoming Investor Conferences
GlobeNewswire
·
April 30, 2025
RESEARCH TRIANGLE PARK, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the following conferences: Citizens Life Sciences Conference in New York on Thursday, May 8, …
Gauzy Ltd. Sets Date for First Quarter 2025 Results
GlobeNewswire
·
April 30, 2025
TEL AVIV, Israel, April 30, 2025 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) (“Gauzy” or the “Company”), a global leader in light and vision control technologies, today announced it will release financial results for the first quarter ended March 31, …
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
April 30, 2025
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update Continuing to advance clinical active immunotherapy portfolio for precision prevention of neurodegenerative diseases Positive immunogenicity and good safety in interim …
Avalo Therapeutics to Participate in The Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
WAYNE, Pa. and ROCKVILLE, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that Dr. Garry Neil, Chief Executive Officer …